449 Documents disponibles dans cette catégorie
The Trans European Drug Information project (TEDI) is a network of European fieldwork Drug Checking services that share their expertise and data within a European monitoring and information system. TEDI's chief aim is to improve public health an[...]
2-(Methylamino)-1-(2-methylphenyl)propan-1-one (2-methylmethcathinone, 2-MMC) is a synthetic cathinone monitored by the EUDA as a new psychoactive substance through the European Union Early Warning System. Based on potential public health risks,[...]
The Trans European Drug Information project (TEDI) is a network of European fieldwork Drug Checking services that share their expertise and data within a European monitoring and information system. The aim of this second trend report is to prese[...]
S. ELLIOTT ; J. EVANS | 2014
Dans Forensic Science International (Vol.243, October 2014) Article : PériodiqueFollowing the initial popularity of mephedrone (4-methylmethcathinone) there has been a stream of new "recreational drugs" entering the global market. The lack of clinical studies on the effects and toxicity of these drugs has made interpretatio[...]
M. COPPOLA ; R. MONDOLA | 2015
Dans Basic and Clinical Pharmacology and Toxicology (Vol.117, n°1, July 2015) Article : PériodiqueIn recent years, the spread of new psychoactive substances has dramatically increased in term of availability of both number of compounds and chemical families. In November 2012, 4,4'-Dimethylaminorex (4,4'-DMAR), a novel synthetic stimulant, wa[...]
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]
1-(4-Bromophenyl)-2-(methylamino)propan-1-one (4-bromomethcathinone, 4-BMC) is a synthetic cathinone monitored by the EUDA as a new psychoactive substance through the European Union Early Warning System. Based on potential public health risks, a[...]
F. LINSEN ; R. P. J. KONING ; M. VAN LAAR ; R. J. M. NIESINK ; M. W. J. KOETER ; T. M. BRUNT | 2015
Dans Addiction (Vol.110, n°7, July 2015) Article : PériodiqueAims: To investigate the temporal pattern of appearance of a new psychoactive substance (4-fluoroamphetamine) on the Dutch drug market, as well as its patterns of use and effects. Design: Data from the Drug Information and Monitoring System (DI[...]
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]
C. HARMEL ; W. CARE ; H. LABORDE-CASTEROT ; M. LIAUTARD ; J. LANGRAND ; L. DUFAYET | 2025
Dans International Journal of Drug Policy (Vol.145, November 2025) Article : PériodiqueIntroduction: 5F-AKB48 is a potent synthetic cannabinoid with psychoactive effects. This study aimed to describe the sociodemographic and clinical characteristics of 5F-AKB48 exposures reported to French Poison Control Centers (PCCs). Methods: [...]
A. TURCANT ; M. DEGUIGNE ; S. FÉREC ; C. BRUNEAU ; I. LEBORGNE ; B. LELIÈVRE ; C. GEGU ; F. JEGOU ; C. ABBARA ; G. LE ROUX ; D. BOELS | 2017
Dans Toxicologie Analytique et Clinique (Vol.29, n°1, Février 2017) Article : PériodiqueFor the last 10 years, recreational use of new psychoactive substances (NPS) with hallucinogenic properties was more and more described either in a context of consumption during a rave-party or at home alone or in small group. A review of 62 cas[...]
J. MELTZER ; A. BOUCHER ; S. COHEN ; J. MORERE | 2025
Dans BMJ Case Reports (Vol.18, n°3, March 2025) Article : PériodiqueWe describe the management by a pre-hospital medical team of a typical opioid toxidrome in a young man after consumption of an unknown substance with complete reversion after injection of unusually high doses of naloxone. The initial toxicolog[...]
Actualités en matière d'addictions. Nouvelles molécules, nouveaux usages, jeux d'argent et de hasard
V. CLERGUE-DUVAL ; J. FLOURIOT ; F. VORSPAN | 2025
Dans Revue du Praticien (La) - Médecine Générale (Tome 39, n°1096, Avril 2025) Article : PériodiqueIl est essentiel de rechercher les addictions associées et dépister les complications (intoxications spécifiques selon le produit, complications des modes d'usage [injections surtout] et dues aux comportements sexuels à risque associés). Il s'a[...]
A. GISH ; A. PEYRE ; C. RICHEVAL ; E. PLEIGNET ; V. COTTEREAU ; J. M. GAULIER ; D. A. DEVAULT | 2025
Dans Environmental Science and Pollution Research (Vol.32, n°53, November 2025) Article : PériodiqueThe emergence of new psychoactive substances (NPS) has made illicit drugs a major health issue. The largest family of NPS is that of synthetic cannabinoid receptor agonists (SCRAs). Due to their widespread use, security authorities are working t[...]
Historique
